With drug pricing almost done, Congress looks to wrap up FDA user fee legislation

With drug pricing almost done, Congress looks to wrap up FDA user fee legislation

Source: 
Endpoints
snippet: 

The Senate won’t return from its summer recess until Sept. 6, but when it does, it officially has 18 business days to finalize the reauthorization of the FDA user fee programs for the next 5 years, or else thousands of drug and biologics reviewers will be laid off and PDUFA dates will vanish in the interim.